Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12. doi: 10.1016/j.cgh.2009.05.033. Epub 2009 Jun 10.
Clin Gastroenterol Hepatol. 2009.
PMID: 19523535
Free PMC article.
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.
Chalasani N, Abdelmalek MF, Garcia-Tsao G, Vuppalanchi R, Alkhouri N, Rinella M, Noureddin M, Pyko M, Shiffman M, Sanyal A, Allgood A, Shlevin H, Horton R, Zomer E, Irish W, Goodman Z, Harrison SA, Traber PG; Belapectin (GR-MD-02) Study Investigators.
Chalasani N, et al.
Gastroenterology. 2020 Apr;158(5):1334-1345.e5. doi: 10.1053/j.gastro.2019.11.296. Epub 2019 Dec 5.
Gastroenterology. 2020.
PMID: 31812510
Free article.
Clinical Trial.
Item in Clipboard
Controversies in the Diagnosis and Management of NAFLD and NASH.
Rinella ME, Loomba R, Caldwell SH, Kowdley K, Charlton M, Tetri B, Harrison SA.
Rinella ME, et al.
Gastroenterol Hepatol (N Y). 2014 Apr;10(4):219-27.
Gastroenterol Hepatol (N Y). 2014.
PMID: 24976805
Free PMC article.
Item in Clipboard
Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.
Kim HP, Idowu MO, Mospan AR, Allmon AG, Roden M, Newsome P, Lok AS, Thuluvath PJ, Taunk J, Fried MW, Sanyal AJ, Barritt AS 4th; TARGET-NASH Investigators.
Kim HP, et al.
Aliment Pharmacol Ther. 2021 Dec;54(11-12):1472-1480. doi: 10.1111/apt.16674. Epub 2021 Oct 25.
Aliment Pharmacol Ther. 2021.
PMID: 34694013
Item in Clipboard
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators.
Younossi ZM, et al.
Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5.
Lancet. 2019.
PMID: 31813633
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite